Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
Open Access
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Saudi Journal of Biological Sciences
- Vol. 28 (5), 3152-3159
- https://doi.org/10.1016/j.sjbs.2021.02.059
Abstract
No abstract availableKeywords
Funding Information
- King Khalid University
This publication has 62 references indexed in Scilit:
- BLAST: a more efficient report with usability improvementsNucleic Acids Research, 2013
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Database resources of the National Center for Biotechnology InformationNucleic Acids Research, 2012
- Medicinal Chemistry and Actions of Dual and Pan PPAR ModulatorsThe Open Medicinal Chemistry Journal, 2011
- Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protectionJournal of Biomedical Science, 2011
- Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitorsJournal of Theoretical Biology, 2008
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular SimulationJournal of Chemical Theory and Computation, 2008
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- Molecular biology of severe acute respiratory syndrome coronavirusCurrent Opinion in Microbiology, 2004
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003